[1] Our Score: 3/5 Our score is based on the latest medical data, customer feedback, and clinic policies
Five studies (n=247) utilised gastric emptying scintigraphy
Experts anticipate an approval filing could occur in late 2026 or 2027 following the conclusion of Phase 3 trials
Glucagon receptor activity increases energy expenditure and modulates fatty acid oxidation useful for body composition and metabolic research
Retatrutide has been studied in controlled laboratory settings to investigate glucose regulation, appetite signals, and metabolic responses across different biological models
However, this appetite suppression can also lead to a decrease in overall food intake, which could result in insufficient intake of essential nutrients, especially protein